"ENZULAMIDE: Optimal Dose Guide for Enzalutamide 40/160mg"

ENZULAMIDE 40 / 160

Enzalutamide (40mg) / (160mg)

Enzalutamide (40mg) / (160mg)

Overview of ENZULAMIDE 40 / 160

ENZULAMIDE 40 / 160 refers to the medication Enzalutamide, available in 40mg and 160mg dosages, primarily used in the treatment of prostate cancer. It is recognized for its effectiveness in targeting and inhibiting the actions of androgens, which are male hormones that can promote tumor growth in the prostate gland.

Mechanism of Action

• Androgen Receptor Inhibition: ENZULAMIDE works by blocking the androgen receptors, preventing the androgens from stimulating cancer cell growth.
• Cancer Cell Growth Reduction: By inhibiting these receptors, ENZULAMIDE 40 / 160 effectively reduces the proliferation of cancer cells in the prostate.

Key Benefits

• Advanced Treatment: Particularly effective in cases of advanced prostate cancer that has become resistant to conventional hormone therapy.
• Oral Convenience: The oral form of ENZULAMIDE 40 / 160 allows for easy administration and adherence to the treatment plan.

Dosage and Administration

• Initial Dose: Often starts with ENZULAMIDE 160 mg once daily, which can be adjusted based on response and tolerability.
• Administration Guidelines: Taken orally, with or without food, and at the same time each day to maintain consistent blood levels.

Side Effects and Management

• Common Side Effects: May include fatigue, hot flushes, hypertension, and musculoskeletal pain.
• Management Strategies: Regular monitoring and symptom management can help mitigate these side effects and maintain patient quality of life.

Comparative Effectiveness

• Research indicates that ENZULAMIDE 40 / 160 is more effective in prolonging survival compared to traditional anti-androgen therapies, especially in patients with metastatic castration-resistant prostate cancer (mCRPC).

Patient Experiences

• Improved Outcomes: Many patients report improved quality of life and reduced disease progression with ENZULAMIDE 40 / 160.
• Treatment Satisfaction: The convenience of oral dosing and the effectiveness of the drug contribute to high patient satisfaction rates.

In summary, ENZULAMIDE 40 / 160 serves as a vital component in the management of advanced prostate cancer, offering a targeted approach that effectively disrupts the growth of cancer cells. Its oral formulation and the potential for improved survival and quality of life make it a preferred choice in prostate cancer therapy.  A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

  BUY NOW